Bayer MaterialScience commissions new hydrogenation technical center
EUR 5 million investment in Chempark Dormagen - Pooling of research activities for the efficient production of MDI and TDI
Dormagen, January 2012 – Bayer MaterialScience has commissioned a new technical center for the development of isocyanate production processes at Chempark Dormagen. The research center was erected in just under a year with an investment of EUR 5 million.
“All global research activities related to the production of aromatic isocyanates have now been
pooled in the new hydrogenation technical center,” said Dr. Joachim Wolff, head of the
polyurethanes business and member of the Executive Committee of Bayer MaterialScience, on the
occasion of the commissioning. “The associated efficiency gains in the research and optimization of
the production processes will help to further expand our global technological leadership.”
The state-of-the-art facility is focused on hydrogenation technology for the production of
precursors to diphenylmethane diisocyanate (MDI) and toluene diisocyanate (TDI). MDI is the
starting product for rigid polyurethane foam, which enables particularly efficient insulation of
buildings, in particular. Over its service life, it saves as much as 70 times more energy than is
needed to produce the foam. TDI is used to make flexible polyurethane foam for comfortable
upholstered furniture and mattresses.
MDI is based on benzene, which is first nitrated into nitrobenzene and then hydrogenated to
produce aniline. An additional step then converts the aniline to diphenylmethane diamine, the
direct precursor to MDI. A catalyst is used to produce aniline from nitrobenzene and hydrogen gas.
With the conventional isothermic process, which is performed at a constant temperature, the
substantial heat generated during the reaction must be dissipated using heat transfer oils. The
reaction takes place inside a reactor block, in which many thousands of tubes containing the
catalyst have been welded together. Finally, the aniline must be painstakingly purified of
byproducts before it can be used further.
The adiabatic variant developed by Bayer MaterialScience is a current example of innovative
process development in the area of hydrogenation. The technology eliminates the need for heat
transfer and enables a substantial gain in efficiency. Here the reaction takes place in a large
steel vessel, in which the catalyst is placed on a grating. The heat of reaction is dissipated
together with the gas flow, eliminating the need for the circulating oil loop. In addition, the
product is also of significantly higher purity. “The technology is already proving to be extremely
successful in our world-scale facility in Shanghai, China, with an annual production capacity of
350,000 metric tons. The conventional process would have been too complex and too expensive for a
facility of this size,” said Dr. Thorsten Dreier, who heads the isocyanate research department at
polyurethane production.
The researchers plan to concentrate on the further optimization of both process variants at
the new technical center. Other focal points will be researching and improving the hydrogenation of
dinitrotoluene to obtain toluene diamine, the direct precursor to TDI, and also the Deacon process
for the oxidation of hydrogen chloride.
It is not just the efficiency of the production processes that plays a central role at the
new technical center. The building itself is state-of-the-art and was designed for sustainability
using innovative materials from the EcoCommercial Building network.
About Bayer MaterialScience:
With 2010 sales of EUR 10.2 billion, Bayer MaterialScience is among the world’s largest
polymer companies. Business activities are focused on the manufacture of high-tech polymer
materials and the development of innovative solutions for products used in many areas of daily
life. The main segments served are the automotive, electrical and electronics, construction and the
sports and leisure industries. At the end of 2010, Bayer MaterialScience had 30 production sites
and employed approximately 14,700 people around the globe. Bayer MaterialScience is a Bayer Group
company.
This news release is available for download from the Bayer MaterialScience press server at
www.press.bayerbms.com.
Find more information at
www.materialscience.bayer.com.
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and
forecasts made by Bayer Group or subgroup management. Various known and unknown risks,
uncertainties and other factors could lead to material differences between the actual future
results, financial situation, development or performance of the company and the estimates given
here. These factors include those discussed in Bayer’s public reports which are available on the
Bayer website at
www.bayer.com. The company assumes no liability
whatsoever to update these forward-looking statements or to conform them to future events or
developments.

Responsible Care